Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
29.06
+0.09 (0.31%)
At close: Aug 21, 2025, 4:00 PM
28.50
-0.56 (-1.93%)
After-hours: Aug 21, 2025, 5:05 PM EDT
Alkermes Employees
Alkermes had 1,800 employees as of December 31, 2024. The number of employees decreased by 300 or -14.29% compared to the previous year.
Employees
1,800
Change (1Y)
-300
Growth (1Y)
-14.29%
Revenue / Employee
$836,276
Profits / Employee
$193,581
Market Cap
4.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,800 | -300 | -14.29% |
| Dec 31, 2023 | 2,100 | -180 | -7.89% |
| Dec 31, 2022 | 2,280 | 69 | 3.12% |
| Dec 31, 2021 | 2,211 | -34 | -1.51% |
| Dec 31, 2020 | 2,245 | 10 | 0.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALKS News
- 22 days ago - Alkermes: A More Than Solid Quarter - Seeking Alpha
- 23 days ago - Alkermes plc (ALKS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Alkermes plc Reports Second Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1 - PRNewsWire
- 5 weeks ago - Alkermes to Report Second Quarter Financial Results on July 29, 2025 - PRNewsWire
- 2 months ago - Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - PRNewsWire
- 2 months ago - Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences - PRNewsWire
- 4 months ago - Alkermes: Label Expansion Of LYBALVI With Ongoing Pediatric Trial Possible - Seeking Alpha